logo
搜索
菜单

的搜索结果

当前371/740页
排序: 最近更新
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
14.9: Pharmacogenomics: Identification of New Drug Targets 01:29 min
14.9: Pharmacogenomics: Identification of New Drug Targets
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase 01:11 min
14.8: Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters 01:16 min
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
14.6: Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase 01:27 min
14.6: Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes 01:28 min
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
14.4: Pharmacogenetics of Drug Metabolism: Overview 01:27 min
14.4: Pharmacogenetics of Drug Metabolism: Overview
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu 01:29 min
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
14.2: Principles of Pharmacogenetics: Types of Genetic Variants 01:27 min
14.2: Principles of Pharmacogenetics: Types of Genetic Variants
14.1: Pharmacogenetics and Pharmacogenomics: Overview 01:29 min
14.1: Pharmacogenetics and Pharmacogenomics: Overview
13.26: Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy 01:26 min
13.26: Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
13.25: Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration 01:25 min
13.25: Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
13.24: Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis 01:30 min
13.24: Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
13.23: Modified-Release Drug Delivery Systems: Rate-Programmed II 01:19 min
13.23: Modified-Release Drug Delivery Systems: Rate-Programmed II
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant 01:25 min
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
13.21: Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration 01:28 min
13.21: Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance 01:25 min
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
13.19: Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate 01:25 min
13.19: Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.17: Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test 01:22 min
13.17: Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
返回顶部